137 related articles for article (PubMed ID: 36118517)
1. Fever-Induced and Early Morning Paroxysmal Dyskinesia in a Man With
Galosi S; Pollini L; Nardecchia F; Cellini E; Guerrini R; Leuzzi V
Mov Disord Clin Pract; 2022 Sep; 9(Suppl 2):S41-S43. PubMed ID: 36118517
[No Abstract] [Full Text] [Related]
2. Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling.
Galosi S; Pollini L; Novelli M; Bernardi K; Di Rocco M; Martinelli S; Leuzzi V
Front Neurol; 2022; 13():886751. PubMed ID: 36003298
[TBL] [Abstract][Full Text] [Related]
3. Scoping Review on ADCY5-Related Movement Disorders.
Menon PJ; Nilles C; Silveira-Moriyama L; Yuan R; de Gusmao CM; Münchau A; Carecchio M; Grossman S; Grossman G; Méneret A; Roze E; Pringsheim T
Mov Disord Clin Pract; 2023 Jul; 10(7):1048-1059. PubMed ID: 37476318
[TBL] [Abstract][Full Text] [Related]
4. Sleep in
Méneret A; Roze E; Maranci JB; Dodet P; Doummar D; Riant F; Tranchant C; Fraix V; Anheim M; Ekmen A; McGovern E; Vidailhet M; Arnulf I; Leu-Semenescu S
J Clin Sleep Med; 2019 Jul; 15(7):1021-1029. PubMed ID: 31383240
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Méneret A; Mohammad SS; Cif L; Doummar D; DeGusmao C; Anheim M; Barth M; Damier P; Demonceau N; Friedman J; Gallea C; Gras D; Gurgel-Giannetti J; Innes EA; Necpál J; Riant F; Sagnes S; Sarret C; Seliverstov Y; Paramanandam V; Shetty K; Tranchant C; Doulazmi M; Vidailhet M; Pringsheim T; Roze E
Mov Disord; 2022 Jun; 37(6):1294-1298. PubMed ID: 35384065
[TBL] [Abstract][Full Text] [Related]
6. Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders.
Delorme C; Giron C; Bendetowicz D; Méneret A; Mariani LL; Roze E
Expert Rev Neurother; 2021 Jan; 21(1):81-97. PubMed ID: 33089715
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
[TBL] [Abstract][Full Text] [Related]
8. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.
Ferrini A; Steel D; Barwick K; Kurian MA
Mov Disord; 2021 May; 36(5):1104-1114. PubMed ID: 33934385
[TBL] [Abstract][Full Text] [Related]
9. A mechanistic review on GNAO1-associated movement disorder.
Feng H; Khalil S; Neubig RR; Sidiropoulos C
Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
[TBL] [Abstract][Full Text] [Related]
10. Paroxysmal movement disorders: An update.
Méneret A; Roze E
Rev Neurol (Paris); 2016; 172(8-9):433-445. PubMed ID: 27567459
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic insights into ADCY5-associated disease.
Chang FC; Westenberger A; Dale RC; Smith M; Pall HS; Perez-Dueñas B; Grattan-Smith P; Ouvrier RA; Mahant N; Hanna BC; Hunter M; Lawson JA; Max C; Sachdev R; Meyer E; Crimmins D; Pryor D; Morris JG; Münchau A; Grozeva D; Carss KJ; Raymond L; Kurian MA; Klein C; Fung VS
Mov Disord; 2016 Jul; 31(7):1033-40. PubMed ID: 27061943
[TBL] [Abstract][Full Text] [Related]
12. Effects of theophylline on ADCY5 activation-From cellular studies to improved therapeutic options for ADCY5-related dyskinesia patients.
Tänzler D; Kipping M; Lederer M; Günther WF; Arlt C; Hüttelmaier S; Merkenschlager A; Sinz A
PLoS One; 2023; 18(3):e0282593. PubMed ID: 36867608
[TBL] [Abstract][Full Text] [Related]
13. ADCY5-related dyskinesia: a case report.
Chen SY; Ho CJ; Lu YT; Lin CH; Tsai MH
Neurol Res Pract; 2022 Aug; 4(1):39. PubMed ID: 35965335
[TBL] [Abstract][Full Text] [Related]
14. Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia.
Erro R; Magrinelli F; Bhatia KP
Handb Clin Neurol; 2023; 196():347-365. PubMed ID: 37620078
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
Chen YZ; Friedman JR; Chen DH; Chan GC; Bloss CS; Hisama FM; Topol SE; Carson AR; Pham PH; Bonkowski ES; Scott ER; Lee JK; Zhang G; Oliveira G; Xu J; Scott-Van Zeeland AA; Chen Q; Levy S; Topol EJ; Storm D; Swanson PD; Bird TD; Schork NJ; Raskind WH; Torkamani A
Ann Neurol; 2014 Apr; 75(4):542-9. PubMed ID: 24700542
[TBL] [Abstract][Full Text] [Related]
16. Genetic Links to Episodic Movement Disorders: Current Insights.
Garg D; Mohammad S; Shukla A; Sharma S
Appl Clin Genet; 2023; 16():11-30. PubMed ID: 36883047
[TBL] [Abstract][Full Text] [Related]
17. Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant.
Reyes NGD; Di Luca DG; McNiven V; Lang AE
Parkinsonism Relat Disord; 2023 Jan; 106():105239. PubMed ID: 36521323
[TBL] [Abstract][Full Text] [Related]
18. Paroxysmal movement disorders - practical update on diagnosis and management.
De Gusmao CM; Silveira-Moriyama L
Expert Rev Neurother; 2019 Sep; 19(9):807-822. PubMed ID: 31353980
[No Abstract] [Full Text] [Related]
19. Movement disorder in
Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.
Koy A; Cirak S; Gonzalez V; Becker K; Roujeau T; Milesi C; Baleine J; Cambonie G; Boularan A; Greco F; Perrigault PF; Cances C; Dorison N; Doummar D; Roubertie A; Beroud C; Körber F; Stüve B; Waltz S; Mignot C; Nava C; Maarouf M; Coubes P; Cif L
J Neurol Sci; 2018 Aug; 391():31-39. PubMed ID: 30103967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
